EMM

EMM

Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation.

EMM is a cluster containing around 20 countries; the majority of which are in the early life cycle stage when compared to other MENA countries in term of capabilities, brand evolution and market readiness. Therefore, In EMM; our goal is to create sustainable value for patients and customers by being one of the best-performing biopharmaceutical companies within the region.

We invest in growth opportunities, including brands such as Crestor and Symbicort – just launched 2 years ago - In addition, we pursue well defined strategy to pave the way for our diabetes fortfolio and Brilinta.

EMM is full of diversified opportunities; having said that and due to the underdeveloped nature of our countries; daily challenges are the norm here. That’s why, talented, motivated and capable people are critical to the successful achievement of our strategic ambitions.

What makes working at EMM office so great?

Our people are our greatest asset....we do our best to create harmony between the different employees and having an open environment with different means of communication which helps creates happier workers and more productive businesses.

The first step to a successful organization is to recognize that we must create an environment in which employees feel inspired and confident that they can be at their best.

Medicines

Trade nameGeneric nameFormulation
ACCOLATE ® Zafirlukast. Tablets containing 20 mg
Arimidex Anastrozole Tablet contains 1 mg
Atacand Candesartan Cilexetil Tablets 4 mg, 8 mg, 16 mg and 32 mg
ATACAND ® PLUS Candesartan Cilexetil And Hydrochlorothiazide 16 mg
candesartan cilexetil and 12.5 mg hydrochlorothiazide
Betaloc ZOK Metoprolol Succinate Tablets 50mg, 100mg and
200 mg
Bricanyl 0.25 mg/dose Terbutaline Sulphate Pressurised metered dose inhaler (pMDI), Each delivered dose contains:
Terbutaline sulphate 0.25 mg
BricanylÔ£® TurbuhalerÔ£® 0.5 mg/dose Terbutaline Sulphate Turbuhaler, Terbutaline sulphate 0.5 mg.
CASODEX ® 50 mg Bicalutamide (Inn Tablets 50 mg
CASODEX ® 150 mg Bicalutamide (Inn Tablets 150 mg
CRESTOR® Rosuvastatin  Tablets 5 mg, 10 mg, 20 mg, 40 mg
DIPRIVAN Propofol  Propofol 10 mg/ml, 20 mg/ml (2%
EMLA ® Lidocaine, Prilocaine 1 g of Emla Cream contains lidocaine
25 mg, prilocaine 25 mg.
INDERAL ® Propranolol Hydrochloride 10 mg, 40 mg or 80 mg Propranolol Hydrochloride
Iressa Gefitinib Tablets 250 mg
Losec® Omeprazole Tablets 20 mg,
MARCAINE ® 0.5% SPINAL HEAVY Bupivacaine Hydrochloride solution for injection: 1 ml contains:
bupivacaine hydrochloride 5.0 mg.
MERONEM ® Meropenem 500 mg, 1 g
NAROPIN ® Ropivacaine Hydrochloride 2 mg/ml, 7.5 mg/ml and 10 mg/ml
Nexium Esomeprazole Tablets 20 mg and 40 mg
NEXIUM 40 mg Esomeprazole 40 mg Powder for solution for injection/infusion
NOLVADEX/ NOLVADEX-D ® Tamoxifen Citrate Nolvadex is available as tablets containing
Tamoxifen Citrate Ph. Eur equivalent to 10
mg of tamoxifen.
Nolvadex-D is available as tablets containing
Tamoxifen Citrate Ph. Eur equivalent to
20 mg of tamoxifen.
OXIS TURBUHALER ® Formoterol Fumarate Dihydrate 4.5 μg/dose and
9μg/dose
PLENDIL ® Felodipine Tablets 5 mg and 10 mg
PULMICORT®, (pMDI) Budesonide 100, 200 and 400 μg/dose
Rhinocort Aqua Budesonide 32 and 64 μg/dose
Seroquel Quetiapine Fumarate 25,100, 200, 300 mg Tablets
Symbicort Turbuhaler Budesonide/Formoterol 80/4.5 μg/dose
Symbicort Turbuhaler Budesonide/Formoterol 160/4.5 μg/dose
Symbicort Turbuhaler 320/9 μg/dose   320/9 μg/dose
TENORETIC 100 Mg Of Atenolol, And 25 Mg Chlorthalidone . Tablets of 100 mg of Atenolol, and 25 mg Chlorthalidone .
TENORMIN ® Atenolol Tablets 50,100 mg
XYLOCAINE ® PUMP, SPRAY 10% Lidocaine
Hydrochloride
1 dose Xylocaine pump spray contains: Lidocaine base 10 mg
XYLOPROCT® 20 mg Lidocaine, Hydrocortisone 1 g Xyloproct ointment contains:
Lidocaine base 50 mg, Hydrocortisone acetate 2.5 mg
1 Xyloproct suppository contains: Lidocaine base 60 mg, Hydrocortisone acetate 5 mg
ZESTORETIC Lisinopril Dihydrate Hydrochlorothiazide Each tablet contains lisinopril dihydrate (equivalent to 20 mg anhydrous lisinopril) and 12.5 mg hydrochlorothiazide
ZESTRIL Lisinopril Dihydrate 5 mg, 10 mg and 20 mg
ZOLADEX® 3.6 mg (Goserelin) Zoladex’ is presented as a sterile, white to
cream coloured cylindrical depot in which
goserelin acetate (equivalent to 3.6 mg of
goserelin
ZOLADEX® 3.6/10.8 mg (Goserelin) Zoladex is presented as a sterile, white
to cream coloured cylindrical depot in which
goserelin acetate (equivalent to 10.8 mg of
goserelin)
Zomig 2.5mg Zolmitriptan  Tablets 2.5mg

 

Adverse event reporting

In case of any adverse event please report it immediately to:

Nivine Borg
nivine.borg@astrazeneca.com

EMM

14C Ahmed Kamel Street
New Maadi
Cairo, 11435
Egypt

Tel: +20 (2)25170661
Fax: +20 (2)25170664